Home Healthcare Medical Devices Calprotectin Testing Market

Calprotectin Testing Market Size, Share & Trends Analysis Report By Sample Type (Fecal Calprotectin, Serum and Plasma Calprotectin, Other Samples), By Assay Technology (Enzyme-Linked Immunosorbent Assay, ELISA, Immunoturbidimetric Assay, Chemiluminescent Immunoassay, Other Immunoassays), By Testing Format (Laboratory-Based Testing, Point-of-Care Testing, Others), By Application (Inflammatory Bowel Disease Diagnosis and Differentiation, Inflammatory Bowel Disease Monitoring, Other Applications), By End User (Diagnostic Laboratories, Hospitals and Specialty Clinics, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: October 23, 2026 | Author: Debashree Bora | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Calprotectin Testing Market, By Sample Type 2025-2034 (USD MILLION/ Units)
    1. Fecal Calprotectin
    2. Serum and Plasma Calprotectin
    3. Other Samples
  2. Calprotectin Testing Market, By Assay Technology 2025-2034 (USD MILLION/ Units)
    1. Enzyme-Linked Immunosorbent Assay, ELISA
    2. Immunoturbidimetric Assay
    3. Chemiluminescent Immunoassay, CLIA
    4. Lateral Flow Immunoassay
    5. Other Immunoassays
  3. Calprotectin Testing Market, By Testing Format 2025-2034 (USD MILLION/ Units)
    1. Laboratory-Based Testing
    2. Point-of-Care Testing
    3. Home Self Testing
  4. Calprotectin Testing Market, By Application 2025-2034 (USD MILLION/ Units)
    1. Inflammatory Bowel Disease Diagnosis and Differentiation
    2. Inflammatory Bowel Disease Monitoring
    3. Systemic Inflammation Assessment
    4. Other Applications
  5. Calprotectin Testing Market, By End User 2025-2034 (USD MILLION/ Units)
    1. Diagnostic Laboratories
    2. Hospitals and Specialty Clinics
    3. Academic and Research Institutes
    4. Home Users
  6. Regional Calprotectin Testing Market
    1. North America
      1. North America Calprotectin Testing Market By Sample Type 2025-2034 (USD MILLION/ Units)
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
      2. North America Calprotectin Testing Market By Assay Technology 2025-2034 (USD MILLION/ Units)
        1. Enzyme-Linked Immunosorbent Assay, ELISA
        2. Immunoturbidimetric Assay
        3. Chemiluminescent Immunoassay, CLIA
        4. Lateral Flow Immunoassay
        5. Other Immunoassays
      3. North America Calprotectin Testing Market By Testing Format 2025-2034 (USD MILLION/ Units)
        1. Laboratory-Based Testing
        2. Point-of-Care Testing
        3. Home Self Testing
      4. North America Calprotectin Testing Market By Application 2025-2034 (USD MILLION/ Units)
        1. Inflammatory Bowel Disease Diagnosis and Differentiation
        2. Inflammatory Bowel Disease Monitoring
        3. Systemic Inflammation Assessment
        4. Other Applications
      5. North America Calprotectin Testing Market By End User 2025-2034 (USD MILLION/ Units)
        1. Diagnostic Laboratories
        2. Hospitals and Specialty Clinics
        3. Academic and Research Institutes
        4. Home Users
      6. U.S.
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
      7. Canada
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
    2. Europe
      1. Europe Calprotectin Testing Market By Sample Type 2025-2034 (USD MILLION/ Units)
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
      2. Europe Calprotectin Testing Market By Assay Technology 2025-2034 (USD MILLION/ Units)
        1. Enzyme-Linked Immunosorbent Assay, ELISA
        2. Immunoturbidimetric Assay
        3. Chemiluminescent Immunoassay, CLIA
        4. Lateral Flow Immunoassay
        5. Other Immunoassays
      3. Europe Calprotectin Testing Market By Testing Format 2025-2034 (USD MILLION/ Units)
        1. Laboratory-Based Testing
        2. Point-of-Care Testing
        3. Home Self Testing
      4. Europe Calprotectin Testing Market By Application 2025-2034 (USD MILLION/ Units)
        1. Inflammatory Bowel Disease Diagnosis and Differentiation
        2. Inflammatory Bowel Disease Monitoring
        3. Systemic Inflammation Assessment
        4. Other Applications
      5. Europe Calprotectin Testing Market By End User 2025-2034 (USD MILLION/ Units)
        1. Diagnostic Laboratories
        2. Hospitals and Specialty Clinics
        3. Academic and Research Institutes
        4. Home Users
      6. U.K.
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
      7. Germany
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
      8. France
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
      9. Spain
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
      10. Italy
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
      11. Russia
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
      12. Nordic
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
      13. Benelux
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
      14. Rest of Europe
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
    3. APAC
      1. APAC Calprotectin Testing Market By Sample Type 2025-2034 (USD MILLION/ Units)
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
      2. APAC Calprotectin Testing Market By Assay Technology 2025-2034 (USD MILLION/ Units)
        1. Enzyme-Linked Immunosorbent Assay, ELISA
        2. Immunoturbidimetric Assay
        3. Chemiluminescent Immunoassay, CLIA
        4. Lateral Flow Immunoassay
        5. Other Immunoassays
      3. APAC Calprotectin Testing Market By Testing Format 2025-2034 (USD MILLION/ Units)
        1. Laboratory-Based Testing
        2. Point-of-Care Testing
        3. Home Self Testing
      4. APAC Calprotectin Testing Market By Application 2025-2034 (USD MILLION/ Units)
        1. Inflammatory Bowel Disease Diagnosis and Differentiation
        2. Inflammatory Bowel Disease Monitoring
        3. Systemic Inflammation Assessment
        4. Other Applications
      5. APAC Calprotectin Testing Market By End User 2025-2034 (USD MILLION/ Units)
        1. Diagnostic Laboratories
        2. Hospitals and Specialty Clinics
        3. Academic and Research Institutes
        4. Home Users
      6. China
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
      7. Korea
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
      8. Japan
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
      9. India
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
      10. Australia
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
      11. Taiwan
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
      12. South East Asia
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
      13. Rest of Asia-Pacific
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
    4. Middle East and Africa
      1. Middle East and Africa Calprotectin Testing Market By Sample Type 2025-2034 (USD MILLION/ Units)
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
      2. Middle East and Africa Calprotectin Testing Market By Assay Technology 2025-2034 (USD MILLION/ Units)
        1. Enzyme-Linked Immunosorbent Assay, ELISA
        2. Immunoturbidimetric Assay
        3. Chemiluminescent Immunoassay, CLIA
        4. Lateral Flow Immunoassay
        5. Other Immunoassays
      3. Middle East and Africa Calprotectin Testing Market By Testing Format 2025-2034 (USD MILLION/ Units)
        1. Laboratory-Based Testing
        2. Point-of-Care Testing
        3. Home Self Testing
      4. Middle East and Africa Calprotectin Testing Market By Application 2025-2034 (USD MILLION/ Units)
        1. Inflammatory Bowel Disease Diagnosis and Differentiation
        2. Inflammatory Bowel Disease Monitoring
        3. Systemic Inflammation Assessment
        4. Other Applications
      5. Middle East and Africa Calprotectin Testing Market By End User 2025-2034 (USD MILLION/ Units)
        1. Diagnostic Laboratories
        2. Hospitals and Specialty Clinics
        3. Academic and Research Institutes
        4. Home Users
      6. UAE
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
      7. Turkey
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
      8. Saudi Arabia
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
      9. South Africa
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
      10. Egypt
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
      11. Nigeria
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
      12. Rest of MEA
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
    5. LATAM
      1. LATAM Calprotectin Testing Market By Sample Type 2025-2034 (USD MILLION/ Units)
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
      2. LATAM Calprotectin Testing Market By Assay Technology 2025-2034 (USD MILLION/ Units)
        1. Enzyme-Linked Immunosorbent Assay, ELISA
        2. Immunoturbidimetric Assay
        3. Chemiluminescent Immunoassay, CLIA
        4. Lateral Flow Immunoassay
        5. Other Immunoassays
      3. LATAM Calprotectin Testing Market By Testing Format 2025-2034 (USD MILLION/ Units)
        1. Laboratory-Based Testing
        2. Point-of-Care Testing
        3. Home Self Testing
      4. LATAM Calprotectin Testing Market By Application 2025-2034 (USD MILLION/ Units)
        1. Inflammatory Bowel Disease Diagnosis and Differentiation
        2. Inflammatory Bowel Disease Monitoring
        3. Systemic Inflammation Assessment
        4. Other Applications
      5. LATAM Calprotectin Testing Market By End User 2025-2034 (USD MILLION/ Units)
        1. Diagnostic Laboratories
        2. Hospitals and Specialty Clinics
        3. Academic and Research Institutes
        4. Home Users
      6. Brazil
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
      7. Mexico
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
      8. Argentina
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
      9. Chile
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
      10. Colombia
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
      11. Rest of LATAM
        1. Fecal Calprotectin
        2. Serum and Plasma Calprotectin
        3. Other Samples
        4. Enzyme-Linked Immunosorbent Assay, ELISA
        5. Immunoturbidimetric Assay
        6. Chemiluminescent Immunoassay, CLIA
        7. Lateral Flow Immunoassay
        8. Other Immunoassays
        9. Laboratory-Based Testing
        10. Point-of-Care Testing
        11. Home Self Testing
        12. Inflammatory Bowel Disease Diagnosis and Differentiation
        13. Inflammatory Bowel Disease Monitoring
        14. Systemic Inflammation Assessment
        15. Other Applications
        16. Diagnostic Laboratories
        17. Hospitals and Specialty Clinics
        18. Academic and Research Institutes
        19. Home Users
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.